Sharon Tetlow
Director/Board Member bij STRUCTURE THERAPEUTICS INC.
Vermogen: - $ op 31-03-2024
Profiel
Sharon E.
Tetlow is the founder and currently holds the position of Managing Partner at Portrero Hill Advisors LLC, which was founded in 2016.
She is also currently serving as a Director at DICE Molecules SV, Inc., Structure Therapeutics, Inc., and Shanghai ShouTi Biotechnology Co. Ltd.
Ms. Tetlow has previously held positions as a Director at Armetheon, Inc., Managing Director at Danforth Advisors LLC from 2013 to 2016, Independent Director at DICE Therapeutics, Inc. from 2020 to 2023, Independent Director at Catalyst Biosciences, Inc. from 2020 to 2022, Independent Director at Altamont Pharma Acquisition Corp.
from 2021 to 2022, CFO, Secretary & SVP-Human Resources at Cell Genesys, Inc. from 2005 to 2009, Venture Partner at Apax Partners, Inc. from 2004 to 2005, Chief Financial Officer at Telik, Inc., Chief Financial Officer at diaDexus, Inc. from 1999 to 2004, Associate at The Brookings Institution, Chief Financial Officer at Reprogenesis, Inc. from 1998 to 1999, Chief Financial Officer at OCERA Therapeutics LLC in 2014, and Chief Financial Officer at Pathwork Diagnostics, Inc. from 2011 to 2013.
Ms. Tetlow is also an Independent Member-Supervisory Board at Valneva SE from 2020 to 2023.
She holds an MBA from Stanford University and an undergraduate degree from the University of Delaware.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-03-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Sharon Tetlow
| Bedrijven | Functie | Begin |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Director/Board Member | 29-03-2022 |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Director/Board Member | - |
| Portrero Hill Advisors LLC | Founder | 01-01-2016 |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Director/Board Member | - |
Eerdere bekende functies van Sharon Tetlow
| Bedrijven | Functie | Einde |
|---|---|---|
| VALNEVA | Director/Board Member | 20-12-2023 |
| DICE THER | Director/Board Member | 09-08-2023 |
| CATALYST BIOSCIENCES | Director/Board Member | 26-12-2022 |
Altamont Pharma Acquisition Corp.
 Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | Director/Board Member | 01-01-2022 |
Danforth Advisors LLC
 Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Corporate Officer/Principal | 01-01-2016 |
Opleiding van Sharon Tetlow
| Stanford University | Masters Business Admin |
| University of Delaware | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VALNEVA | Health Technology |
| Bedrijven in privébezit | 18 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Finance |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
The Brookings Institution
 The Brookings Institution Miscellaneous Commercial ServicesCommercial Services The Brookings Institution provides research and policy solutions. The firm's activities are carried out through four research programs: economic studies, foreign policy studies, governance studies, and metropolitan policy. The company was founded in 1916 and is headquartered in Washington, DC. | Commercial Services |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Health Technology |
Ocera Therapeutics, Inc.
 Ocera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ocera Therapeutics, Inc. manufactures pharmaceuticals products. The company was founded in 2004 and is headquartered in Hazelwood, MO. | Health Technology |
Pathwork Diagnostics, Inc.
 Pathwork Diagnostics, Inc. Medical SpecialtiesHealth Technology Pathwork Diagnostics Inc. develops and delivers molecular diagnostics for oncology. The company was founded by Glenda Anderson, Richard Zare, and George M. Whitesides in 2003 and is headquartered in Redwood City, CA. | Health Technology |
| Reprogen, Inc. | |
Armetheon, Inc.
 Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Health Technology |
Danforth Advisors LLC
Danforth Advisors LLC Investment ManagersFinance Danforth Advisors LLC provides advisory services. It offers finance support and stratigic consultation services for life science firm. The company was founded by Gregg Beloff and Daniel Geffken and is headquartered in Southborough, MA. | Finance |
DICE Therapeutics, Inc.
 DICE Therapeutics, Inc. BiotechnologyHealth Technology DiCE Therapeutics, Inc. is a biopharmaceutical company, which designs and develops a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company was founded by J. Kevin Judice on August 14, 2013 and is headquartered in South San Francisco, CA. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
DICE Molecules SV, Inc.
DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Finance |
| Portrero Hill Advisors LLC | |
| Structure Therapeutics, Inc. | |
Altamont Pharma Acquisition Corp.
Altamont Pharma Acquisition Corp. Financial ConglomeratesFinance Altamont Pharma Acquisition Corp. is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on January 6, 2021 and is headquartered in Austin, TX. | Finance |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The private company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Health Technology |
